When lightning strikes twice: these 15 extraordinary rock musicians who conquered the charts and built legendary legacies ...

CLEVELAND, May 13, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter of 2026, highlighting commercial momentum for ZEVASKYN.

Liberate Bio, Inc., a biotechnology company developing genetic medicines that deliver RNA therapies directly to immune cells, today announced new pre-clinical data supporting LIB820, the company’s ...

Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from long-term global ...

Longevity, the length of human life, is the subject of growing scientific and commercial interest. Click here to read more.

The early history of personal computers is stacked with systems such as the Apple II and the Commodore 64 that had the ...

Scientists in Japan found that arginine, a common amino acid already used in supplements and medicine, reduced harmful ...

In 2012, neuroscientist Gary Landreth and his team at Case Western Reserve University published a finding in Science that ...

Three patients treated with ZEVASKYN- in Q1 2026 - - QTC network expands to six sites, with two new additions on the East Coast - - In-licensed radically novel engineered T-cell technology with game ...

Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from long-term global investors. Proceeds are expected to fund the Company through ...

The ringing started three weeks after the prescription did. That is the kind of story audiologists and psychiatrists have ...